RESERVED AREA     |
MINDDS
  • Home
  • News
  • MINDDS
  • Activities
    • Meetings
    • Training Schools
    • STSM
    • Conference Grants
    • Publications
  • WG
    • WG1: Patient Cohort Framework
    • WG2: Clinical Phenotyping
    • WG3: Emerging Technologies
    • WG4: Databases and informatics
    • WG5: Integration and Convergence
  • Members
    • Core Group
    • Management Committee
    • Working Groups
    • Participants
    • International Partner countries
    • Geographical Distribution
  • Partners
    • Universities
    • Hospital & Clinical Hospitals
    • Research Institutes
    • Industries
    • Public Health Institutions
    • National Organizations
  • Knowledge Nexus
    • Survey
    • Researchers
    • Clinicians
    • Patients & Families
MINDDS
  • Home
  • News
  • MINDDS
  • Activities
    • Meetings
    • Training Schools
    • STSM
    • Conference Grants
    • Publications
  • WG
    • WG1: Patient Cohort Framework
    • WG2: Clinical Phenotyping
    • WG3: Emerging Technologies
    • WG4: Databases and informatics
    • WG5: Integration and Convergence
  • Members
    • Core Group
    • Management Committee
    • Working Groups
    • Participants
    • International Partner countries
    • Geographical Distribution
  • Partners
    • Universities
    • Hospital & Clinical Hospitals
    • Research Institutes
    • Industries
    • Public Health Institutions
    • National Organizations
  • Knowledge Nexus
    • Survey
    • Researchers
    • Clinicians
    • Patients & Families

Members

MINDDSMembers

Members

  • Core Group
  • Management Committee
  • Working Groups
  • Participants
  • International Partner countries
  • Geographical Distribution

Latest Updates

  • 14th Troina Meeting on Genetics of Neurodevelopmental Disorders 28th May 2019
  • 16p11.2: rare genetic changes linked to autism now connected to higher chance of other psychiatric disorders 6th March 2019

Download MoU 860 KB

MINDDS

Understanding rare neurodevelopmental disorders (NDD) has the potential drive major new therapies for the common NDD of schizophrenia and Autism Spectrum Disorder (ASD).

Know More

Quick links

  • News
  • MINDDS
  • Activities
  • WG
  • Members
  • Partners

Connect with us

Have a question? Click here or send us an email to info@mindds.eu
Sign up for MINDDS articles and resources:


Cost Action

2019 © MINDDS | Privacy Policy | Design by Boutik
Go to Top

MINDDS

Understanding rare neurodevelopmental disorders (NDD) has the potential drive major new therapies for the common NDD of schizophrenia and Autism Spectrum Disorder (ASD).

Download MoU 860 KB